Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jun 22;12(6):e8772.
doi: 10.7759/cureus.8772.

Olanzapine as an Adjunct in the Management of Refractory Psychogenic Excoriation With Comorbid Schizophrenia: A Case Report

Affiliations
Case Reports

Olanzapine as an Adjunct in the Management of Refractory Psychogenic Excoriation With Comorbid Schizophrenia: A Case Report

Violet Yeager et al. Cureus. .

Abstract

Neurotic or psychogenic excoriation (PE) is one of the most commonly diagnosed skin disorders associated with a primary psychiatric condition. PE is characterized by excessive picking and scratching of normal-appearing skin, and is often comorbid or is an inherent manifestation of affective disturbance and psychosis itself in schizophrenia. Evidence in the literature has demonstrated the therapeutic efficacy of selective serotonin reuptake inhibitors (SSRI) in treating PE. Other pharmacological treatments that have shown therapeutic benefits in case reports include doxepin, clomipramine, naltrexone, pimozide, and olanzapine. However, using adjunct therapeutic methods or augmentation in the treatment of neurogenic excoriation in the setting of schizophrenia is still not well explored. In this study, we discuss the case of a 59-year-old medically complex paraplegic male with schizophrenia comorbid with severe refractory PE. The patient had poor adherence to psychopharmacological treatment. Consequently, the patient was repeatedly hospitalized due to acute exacerbations of schizophrenic episodes and self-mutilation due to PE. After several failed treatment approaches, olanzapine 10 mg PO BID was added as an adjunct therapy to the Haldol® Decanoate (Janssen Pharmaceutica, Beerse, Belgium) at a dosage of 100 mg/month intramuscularly to control the acute PE symptoms. This treatment modality proved successful in this case, and the patient has been free from PE relapse for over one year of close follow-up. Olanzapine along with Haldol Decanoate long-acting injectable (LAI), might, therefore, be a useful adjunct therapeutic modality for patients with refractory PE with a comorbid diagnosis of schizophrenia and warrants further research.

Keywords: haldol decanoate; long acting injectable; olanzapine; psychogenic excoriation; schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Severe refractory psychogenic excoriation - self-inflicted wounds
Figure 2
Figure 2. Patient after remission of psychogenic excoriation

References

    1. Obsessive-compulsive and related disorders: a critical review of the new diagnostic class. Abramowitz JS, Jacoby RJ. Annu Rev Clin Psychol. 2015;11:165–186. - PubMed
    1. Skin-picking disorder a guide to diagnosis and management. Jafferany M, Patel A. CNS Drugs. 2019;33:337–346. - PubMed
    1. Should skin picking disorder be considered a diagnostic category? A systematic review of the evidence. Jenkins Z, Zavier H, Phillipou A, Castle D. Aust N Z J Psychiatry. 2019;53:866–877. - PubMed
    1. The relation of psychogenic excoriation with psychiatric disorders: a comparative study. Calikuşu C, Yücel B, Polat A, Baykal C. Compr Psychiatry. 2003;44:256–261. - PubMed
    1. Management of obsessive-compulsive disorder-related skin picking with gamma knife radiosurgical anterior capsulotomies: a case report. Kondziolka D, Hudak R. J Clin Psychiatry. 2008;69:1337–1340. - PubMed

Publication types

LinkOut - more resources